DK0465343T3 - Farmaceutisk eller kosmetisk præparat indeholdende en kombination af et retinoid og en sterol - Google Patents

Farmaceutisk eller kosmetisk præparat indeholdende en kombination af et retinoid og en sterol

Info

Publication number
DK0465343T3
DK0465343T3 DK91401805.6T DK91401805T DK0465343T3 DK 0465343 T3 DK0465343 T3 DK 0465343T3 DK 91401805 T DK91401805 T DK 91401805T DK 0465343 T3 DK0465343 T3 DK 0465343T3
Authority
DK
Denmark
Prior art keywords
combination
retinoid
sterol
pharmaceutical
composition containing
Prior art date
Application number
DK91401805.6T
Other languages
English (en)
Inventor
Uwe Reichert
Rainer Schmidt
Braham Shroot
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird Galderma filed Critical Cird Galderma
Application granted granted Critical
Publication of DK0465343T3 publication Critical patent/DK0465343T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK91401805.6T 1990-07-02 1991-07-02 Farmaceutisk eller kosmetisk præparat indeholdende en kombination af et retinoid og en sterol DK0465343T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9008344A FR2663850B1 (fr) 1990-07-02 1990-07-02 Composition pharmaceutique ou cosmetique contenant en association un retinouide et un sterol.

Publications (1)

Publication Number Publication Date
DK0465343T3 true DK0465343T3 (da) 1994-10-03

Family

ID=9398240

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91401805.6T DK0465343T3 (da) 1990-07-02 1991-07-02 Farmaceutisk eller kosmetisk præparat indeholdende en kombination af et retinoid og en sterol

Country Status (11)

Country Link
US (2) US5556844A (da)
EP (1) EP0465343B1 (da)
JP (1) JP3224228B2 (da)
AT (1) ATE107169T1 (da)
AU (1) AU8183691A (da)
CA (1) CA2086429C (da)
DE (1) DE69102499T2 (da)
DK (1) DK0465343T3 (da)
ES (1) ES2055972T3 (da)
FR (1) FR2663850B1 (da)
WO (1) WO1992000076A1 (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753239A (en) * 1991-05-15 1998-05-19 Centre International De Recherches Dematologiques Galderma (Cird Galderma) Bi-aromatic compounds and pharmaceutical and cosmetic compositions
US5869067A (en) * 1991-05-15 1999-02-09 Centre International De Recherches Dermatologiques Galderma (Cird Galderma) Bi-aromatic compounds and pharmaceutical and cosmetic compositions
FR2681784B1 (fr) * 1991-10-01 1995-06-09 Fabre Pierre Cosmetique Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides.
US5874059A (en) * 1992-04-02 1999-02-23 Fundacao E.J. Zerbini Microemulsions labelled with radioactivity used as means for targeting neoplastic cells
FR2723315B1 (fr) * 1994-08-02 1996-10-25 Cird Galderma Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes
IL110943A (en) * 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
FR2729854A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
EP0738510A3 (fr) * 1995-04-20 2005-12-21 L'oreal Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes
DE19537027A1 (de) * 1995-10-05 1997-04-10 Beiersdorf Ag Hautpflegemittel für alte Haut
RU2135127C1 (ru) * 1996-07-02 1999-08-27 Святослав Николаевич Федоров Раствор для защиты и лечения заболеваний и повреждений роговицы "визитин"
FR2753627B1 (fr) * 1996-09-20 2003-02-21 Galderma Rech Dermatologique Utilisation des inhibiteurs de l'activite de l'acide retinoique pour favoriser la cicatrisation
RU2126668C1 (ru) * 1996-10-17 1999-02-27 Багров Сергей Николаевич Мазь для лечения блефаритов "демалон"
FR2755965B1 (fr) 1996-11-19 1998-12-18 Cird Galderma Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
FR2759292B1 (fr) * 1997-02-10 2000-08-11 Cird Galderma Utilisation de retinoides en tant qu'agents induisant la pigmentation
US6306426B1 (en) * 1997-08-11 2001-10-23 Allergan Sales, Inc. Implant device with a retinoid for improved biocompatibility
EP0985404A4 (en) * 1998-02-10 2002-07-31 Shiseido Co Ltd AQUEOUS TYPE EMULSIONATED COMPOSITION
JP3634139B2 (ja) * 1998-02-10 2005-03-30 株式会社資生堂 水中油型乳化組成物
US6071955A (en) * 1999-02-25 2000-06-06 The Regents Of The University Of California FXR, PPARA and LXRA activators to treat acne/acneiform conditions
EP1214303A1 (en) * 1999-08-31 2002-06-19 Merck & Co., Inc. Heterocyclic compounds and methods of use thereof
US6982284B1 (en) 1999-09-10 2006-01-03 Applied Genetics Incorporated Dermatics Compositions and methods for modification of skin lipid content
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
US20020010128A1 (en) * 2000-04-13 2002-01-24 Parks Thomas P. Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
FR2825918B1 (fr) * 2001-06-14 2005-01-21 Alfred Denner Procede cosmetique du traitement des vergetures
AU2003302305A1 (en) * 2002-12-31 2004-07-22 Sachin S Bhagwat Benzoquinolizine-2-carboxylic acid-containing compositions
EP1578449A2 (en) * 2002-12-31 2005-09-28 Wockhardt Limited Compositions of benzoquinolizine carboxylic acid antibiotic drugs
GB0311815D0 (en) 2003-05-22 2003-06-25 Unilever Plc Skin treatments
DE102004002606A1 (de) * 2004-01-15 2005-08-04 Beiersdorf Ag Visualisierung von Sonnenschutzmitteln auf der Haut
US20080255244A1 (en) * 2007-04-11 2008-10-16 Fred Hutchinson Cancer Research Center CaM Kinase II Inhibitor Improves Retinoic Acid Therapy and Inhibits the Proliferation of Myeloid Leukemia Cells
US8500688B2 (en) 2009-04-16 2013-08-06 Medtronic, Inc. Retrograde coronary sinus perfusion cannula and methods of using same
GB0915196D0 (en) 2009-09-01 2009-10-07 King S College London Therapeutic compounds and their use
EP2736332A4 (en) * 2011-07-29 2015-03-18 Tempero Pharmaceuticals Inc CONNECTIONS AND METHODS
US8772273B2 (en) * 2011-10-04 2014-07-08 Quretino Therapeutics, Inc. Formulations and uses of retinoic acid receptor selective agonists
WO2014145295A1 (en) 2013-03-15 2014-09-18 Avisenna Cosmetics, Llc Topical compositions for reducing aging effects
WO2015026990A2 (en) 2013-08-20 2015-02-26 University Of Washington Through Its Center For Commercialization Novel and specific inhibitors of cytochrome p450 26 retinoic acid hydrolase
US10328040B2 (en) 2014-01-17 2019-06-25 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic methods
WO2015130973A1 (en) * 2014-02-26 2015-09-03 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US20170114019A1 (en) * 2014-06-04 2017-04-27 Haro Pharmaceutical Inc. 18-20 member bi-polycyclic compounds
US20180250313A1 (en) * 2015-09-08 2018-09-06 Viewpoint Therapeutics, Inc. Compounds and formulations for treating ophthalmic diseases
US11364216B2 (en) 2016-09-29 2022-06-21 Biogem S.C. A R.L. Retinoid derivatives with antitumor activity
EP3301085A1 (en) * 2016-09-29 2018-04-04 Biogem S.Ca.R.L. Retinoid derivatives with antitumor activity
US10238655B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Dihydroindene and tetrahydronaphthalene compounds
US10231947B2 (en) 2017-01-23 2019-03-19 Arizona Board Of Regents On Behalf Of Arizona State University Isochroman compounds and methods of use thereof
US10238626B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87201A1 (fr) * 1988-04-14 1989-11-14 Cird Complexes a base d'anthraline et d'un sterol,leur procede d'obtention et leur utilisation en therapeutique et cosmetique

Also Published As

Publication number Publication date
DE69102499D1 (de) 1994-07-21
EP0465343B1 (fr) 1994-06-15
EP0465343A1 (fr) 1992-01-08
AU8183691A (en) 1992-01-23
JPH06501458A (ja) 1994-02-17
FR2663850B1 (fr) 1994-01-14
FR2663850A1 (fr) 1992-01-03
US5556844A (en) 1996-09-17
US5587367A (en) 1996-12-24
ES2055972T3 (es) 1994-09-01
ATE107169T1 (de) 1994-07-15
WO1992000076A1 (fr) 1992-01-09
CA2086429A1 (fr) 1992-01-03
DE69102499T2 (de) 1995-01-05
CA2086429C (fr) 1999-09-21
JP3224228B2 (ja) 2001-10-29

Similar Documents

Publication Publication Date Title
DK0465343T3 (da) Farmaceutisk eller kosmetisk præparat indeholdende en kombination af et retinoid og en sterol
IT9048260A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
BR9106891A (pt) Composiçoes para o tratamento da pele
PT841898E (pt) COMPOSICOES TóPICAS QUE PROPORCIONAM UMA MELHOR SENSACAO DA PELE
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
DE59508891D1 (de) Hautpflegemittel
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
AU1798995A (en) Use of extracts of filamentous bacteria as cosmetic agents to combat ageing of the skin
ES2158597T3 (es) Compuestos bioaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
YU113391A (sh) 2,4 i 2,5 substituirani piridin-n oksidi i postupak za njihovu proizvodnju
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
NO985980L (no) Lektinpreparater og anvendelser derav
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
BR9702144A (pt) Compostos propinil biaromáticos composição farmacêutica composição cosmética e utilização de uma composição cosmética
BG101126A (en) The use of muramylpeptide compounds
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
IT1240683B (it) Composizione farmaceutica contenente egf
DK0388275T3 (da) Dermatologiske og kosmetoligiske præparater, der er baseret på alkylcarboxamid og zinksalte og er nyttige til behandling af serborrhoisk dermatitis og/eller serborrhoiske lidelser
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
DE60003074D1 (de) Fusidinsäure-derivate
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
KR980000458A (ko) 인삼 사포닌 성분을 함유하는 상처 치유용 조성물